NeuMoDx President & COO Sundu Brahmasandra speaking about the partnership with QIAGEN

At ESCV in Athens, Greece, following the official launch of the NeuMoDx platform, President & COO Sundu Brahmasandra explains the advantages of the N96 and N288 for Molecular Diagnosics and what to expect from the partnership with QIAGEN going forward.